Artificial Pancreas Device Market 2024 | Industry Analysis | Growth Opportunities | Forecast 2024 Emergen Research continues to strengthen its position in the market intelligence space by introducing its advanced Artificial Pancreas Device market research content, designed to help organizations navigate complex and evolving business environments. This newly developed content library focuses on delivering meaningful insights that allow businesses to improve decision-making and identify long-term growth opportunities across multiple industries. Artificial Pancreas Device Market Size and Overiew The artificial pancreas device market is expected to grow from an estimated USD 0.3 billion in 2024 to USD 1.5 billion in 2033 at a CAGR of 19.20%. The global artificial pancreas device market size is expected to grow from 0.3 billion by the end of 2024 to 1.5 billion by 2033, registering a revenue CAGR of 19.20% during the forecast period. The artificial pancreas device market is anticipated to grow due to factors such as rising cases of Type 1 diabetes, robust research and development efforts by pharmaceutical companies, and rising demand for automated systems for glycemic control. New technologies has been developed to improves type 1 diabetes management. For instance, in September 2022, according to a new multicenter clinical trial, a device called a bionic pancreas, which uses next-generation technology to deliver insulin automatically, was more successful than standard-of-care management at keeping blood glucose (sugar) levels within the normal range in individuals with type 1 diabetes. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health, provided the majority of the funding for the trial, which was then published in the New England Journal of Medicine. The increasing geriatric population, growing prevalence of diabetes, and rising incidence of obesity are also estimated to favour the demand for artificial pancreas devices over the coming years. For instance, according to the World Health Organisation, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. According to the International Diabetes Federation, approximately 537 million persons ages 20 to 79 have diabetes, and the figure is predicted that it will rise from 643 million by 2030 to 783 million by 2045. Furthermore, according to the World Health Organisation, in 2022, 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity. Hence, The aforementioned figures demonstrate how the increase in these illnesses is driving up demand for medical equipment, which supports market expansion. One of the most valuable aspects of this research is its strong emphasis on continuous updates and relevance. In today’s fast-changing market conditions, relying on outdated information can lead to poor strategic decisions. Emergen Research ensures that its content reflects the latest developments, trends, and industry shifts, allowing businesses to stay competitive and adapt their strategies effectively over time. The research content is structured in a way that simplifies complex data and presents it in an easily understandable format. Instead of overwhelming users with excessive information, the report focuses on clarity and usability. This approach makes it suitable for a wide range of stakeholders, including investors, business owners, consultants, and policymakers who require actionable insights without unnecessary complexity. Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4028